Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders | MicrobiomeTrials← Back to trialsNCT00895271
Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Enrollment target: 200 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
DOCK8 Deficiency
Background:
-DOCK8 deficiency is a genetic disorder that affects the immune system and can lead to severe recurrent inf…
Bethesda, United StatesEst. completion Oct 31, 2026
HIV
There is evidence that early and aggressive treatment with antiretroviral drugs can prevent the loss of immune cell func…
Bethesda, United States
Chronic Graft vs. Host Disease
Background:
* Chronic graft-versus-host disease (cGVHD) is a multi-organ alloimmune and autoimmune disorder that occurs…